Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.52 USD | +0.82% | +2.15% | +1.38% |
May. 09 | Arecor Therapeutics collaborates with Medtronic on novel insulin | AN |
May. 09 | Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development | MT |
Financials (USD)
Sales 2024 * | 32.24B | Sales 2025 * | 33.57B | Capitalization | 110B |
---|---|---|---|---|---|
Net income 2024 * | 4.56B | Net income 2025 * | 5.24B | EV / Sales 2024 * | 4.1 x |
Net Debt 2024 * | 22.21B | Net Debt 2025 * | 21.12B | EV / Sales 2025 * | 3.91 x |
P/E ratio 2024 * |
23.8
x | P/E ratio 2025 * |
20.6
x | Employees | 95,000 |
Yield 2024 * |
3.3% | Yield 2025 * |
3.46% | Free-Float | 99.81% |
Latest transcript on Medtronic plc
1 day | +0.82% | ||
1 week | +2.15% | ||
Current month | +4.09% | ||
1 month | +4.23% | ||
3 months | -0.08% | ||
6 months | +15.87% | ||
Current year | +1.38% |
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 15-01-25 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 16-05-31 |
Gregory Smith
COO | Chief Operating Officer | 63 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 12-12-31 |
Kendall Powell
BRD | Director/Board Member | 70 | 06-12-31 |
Randall Hogan
BRD | Director/Board Member | 68 | 14-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.07% | 17 M€ | +6.60% | - | |
2.45% | 13,519 M€ | +6.49% | ||
2.26% | 6 M€ | +16.84% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 83.52 | +0.82% | 4,950,839 |
24-05-10 | 82.84 | +0.10% | 4,217,841 |
24-05-09 | 82.76 | +1.48% | 5,545,720 |
24-05-08 | 81.55 | -0.43% | 4,175,665 |
24-05-07 | 81.9 | +0.17% | 4,939,733 |
Delayed Quote Nyse, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.38% | 110B | |
-4.82% | 182B | |
-2.82% | 68.11B | |
+0.69% | 50.53B | |
+8.54% | 44.8B | |
+2.84% | 40.7B | |
+20.50% | 32.25B | |
+1.72% | 26.53B | |
+15.25% | 25.02B | |
-1.73% | 24.96B |
- Stock Market
- Equities
- MDT Stock